|
331 |
Placebo
München : Columbia International, 2024-08-02
|
|
|
|
332 |
Placebo-Glaube
Michaeli, Stefan. - Norderstedt : BoD - Books on Demand, 2024, 1. Auflage
|
|
|
|
333 |
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects
Aicher, Helena D.. - Freiburg : Universität, 2024
|
|
|
|
334 |
Protein Supplementation Increases Adaptations to Low-Volume, Intra-Session Concurrent Training in Untrained Healthy Adults: A Double-Blind, Placebo-Controlled, Randomized Trial
Reljic, Dejan. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2024
|
|
|
|
335 |
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)
Wolff, Andreas W.. - Ludwig-Maximilians-Universität München, 2024
|
|
|
|
336 |
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation
Singer, Berit. - Freiburg : Universität, 2024
|
|
|
|
337 |
Randomized controlled clinical trial on the efficacy of a novel antimicrobial chewing gum in reducing plaque and gingivitis in adolescent orthodontic patients
Weber, Johanna. - Freiburg : Universität, 2024
|
|
|
|
338 |
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study
Bavendiek, Udo. - Würzburg : Universität Würzburg, 2024
|
|
|
|
339 |
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
Behrens, Frank. - Würzburg : Universität Würzburg, 2024
|
|
|
|
340 |
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS)
Koch, Jan Christoph. - Ludwig-Maximilians-Universität München, 2024
|
|
Administration
